A five-day treatment course of zanamivir for the flu with a single, self-administered, painless microneedle array patch: Revolutionizing delivery of poorly membrane-permeable therapeutics
Dawn Reyna, Ian Bejster, Aaron M. Chadderdon, Cheryl Harteg, Qonita Kurnia Anjani, Akmal Hidayat Bin Sabri, Ashley N. Brown, George L. Drusano, Jonna B. Westover, E. Bart Tarbet, Lalitkumar K. Vora, Ryan F. Donnelly, Elke Lipka
Topics & Concepts
ZanamivirNeuraminidase inhibitorPharmacologyMedicineNeuraminidaseRoute of administrationPharmacokineticsGelatinChemistryVirusVirologyInternal medicineBiochemistryDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Influenza Virus Research StudiesTransgenic Plants and ApplicationsRespiratory viral infections research